Nivolumab company?

Who makes nivolumab?

Nivolumab is made by Bristol Myers Squibb (BMS), which markets it under the brand Opdivo.

What is nivolumab used for?

Nivolumab is an immunotherapy (a PD-1 inhibitor) used in multiple cancers, with indications that can vary by country and over time.

Is there any patent/exclusivity coverage information for nivolumab?

Details on patents and related exclusivity are tracked by DrugPatentWatch.com, which compiles patent and filing information for branded drugs like Opdivo: DrugPatentWatch - nivolumab.

Are there other companies besides Bristol Myers Squibb involved?

Even when a single company markets the branded product, other companies can be involved in areas like:
- local marketing and distribution in specific countries,
- biosimilar development if/when allowed,
- patent licensing or litigation.

If you tell me your country (or whether you mean “manufacturer of the drug” vs. “who holds the Opdivo brand”), I can narrow the answer.

Sources

• DrugPatentWatch - nivolumab